Search for Clinical Trial Results
Chronic Myelomonocytic Leukemia - 28 Studies Found
Status | Study |
Completed |
Study Name: Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia Condition:
Date: 2008-06-27 Interventions: Drug: Clofarabine Clofarabine is a rationally designed, second generation purine nucleoside analogue. Cl |
Active, not recruiting |
Study Name: Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment) Condition:
Date: 2014-03-07 Interventions: Other: Either Wait and See, or Supportive Treatment, or Active Treatment at physician discretion As desc |
Completed |
Study Name: Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia Condition:
|
Recruiting |
Study Name: Phase 1 Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Splicing Modulator H3B-8800 for Subjects With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia Condition:
|
Active, not recruiting |
Study Name: A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML). Condition:
Date: 2009-07-07 Interventions: |
Completed |
Study Name: Volasertib in Combination With Azacitidine in Japanese Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia Condition:
Interventions: |
Recruiting |
Study Name: Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed Condition:
Date: 2016-10-13 Interventions: |
Completed |
Study Name: A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) Patients Condition:
|
Completed |
Study Name: A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML) Condition:
|
Completed |
Study Name: Azacitidine in Treating Patients With Chronic Myelomonocytic Leukemia Condition: Leukemia Date: 2010-11-04 Interventions:
|